THIRD AMENDMENT TO SECURED CONVERTIBLE CREDIT AND SECURITY AGREEMENTSecured Convertible Credit and Security Agreement • November 15th, 2024 • Armata Pharmaceuticals, Inc. • Biological products, (no disgnostic substances)
THIRD AMENDMENT TO SECURED CONVERTIBLE CREDIT AND SECURITY AGREEMENT, dated as of November 12, 2024 (this “Amendment”), by and among Armata Pharmaceuticals, Inc., a Washington corporation (the “Borrower”), each Guarantor from time to time party to the Credit Agreement (as defined below) (the “Guarantors” and, together with the Borrower, the “Loan Parties”) and Innoviva Strategic Opportunities LLC, a Delaware limited liability company, or an affiliate thereof (the “Lender”).
FIRST AMENDMENT TO SECURED CONVERTIBLE CREDIT AND SECURITY AGREEMENTSecured Convertible Credit and Security Agreement • July 11th, 2023 • Armata Pharmaceuticals, Inc. • Biological products, (no disgnostic substances)
FIRST AMENDMENT TO SECURED CONVERTIBLE CREDIT AND SECURITY AGREEMENT, dated as of July 10, 2023 (this “Amendment”), by and among Armata Pharmaceuticals, Inc., a Washington corporation (the “Borrower”), each Guarantor from time to time party to the Credit Agreement (as defined below) (the “Guarantors” and, together with the Borrower, the “Loan Parties”) and Innoviva Strategic Opportunities LLC, a Delaware limited liability company, or an affiliate thereof (the “Lender”).
SECOND AMENDMENT TO SECURED CONVERTIBLE CREDIT AND SECURITY AGREEMENTSecured Convertible Credit and Security Agreement • March 4th, 2024 • Armata Pharmaceuticals, Inc. • Biological products, (no disgnostic substances)
SECOND AMENDMENT TO SECURED CONVERTIBLE CREDIT AND SECURITY AGREEMENT, dated as of March 4, 2024 (this “Amendment”), by and among Armata Pharmaceuticals, Inc., a Washington corporation (the “Borrower”), each Guarantor from time to time party to the Credit Agreement (as defined below) (the “Guarantors” and, together with the Borrower, the “Loan Parties”) and Innoviva Strategic Opportunities LLC, a Delaware limited liability company, or an affiliate thereof (the “Lender”).
Secured Convertible Credit and Security Agreement Dated as of January 10, 2023 by and among ARMATA PHARMACEUTICALS, INC., as the Borrower, EACH SUBSIDIARY OF THE BORROWER HERETO FROM TIME TO TIME, as Guarantors, and INNOVIVA STRATEGIC OPPORTUNITIES...Secured Convertible Credit and Security Agreement • January 10th, 2023 • Armata Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
Secured Convertible Credit and Security Agreement, dated as of January 10, 2023, by and among Armata Pharmaceuticals, Inc., a Washington corporation (the “Borrower”), each Subsidiary of the Borrower listed as a “Guarantor” on the signature pages hereto (together with each other Person that executes a joinder agreement and becomes a “Guarantor” hereunder or otherwise guarantees all or any part of the Obligations (as hereinafter defined), each a “Guarantor” and collectively, the “Guarantors”) and Innoviva Strategic Opportunities LLC, a Delaware limited liability company, or an affiliate thereof, as the lender (the “Lender”).
